Frontlight ResearchEarly access
Trial site
Parkville
- 9running trials
- 4closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Multiple sclerosis4 trials
- Chronic spontaneous urticaria2 trials
- Glioblastoma2 trials
- Hidradenitis suppurativa2 trials
- IgA nephropathy2 trials
- Acute myeloid leukaemia1 trial
- Childhood cancers1 trial
- Chronic kidney disease1 trial
- Liver and biliary tract cancer1 trial
- Myelodysplastic syndromes1 trial
- Neuroblastoma1 trial
- Neurofibromatosis type 11 trial
- and 1 more
- Phase
- Phase 311 trials
- Phase 11 trial
- Phase 41 trial
- Status
- Active, not recruiting7 trials
- Completed4 trials
- Recruiting2 trials
- Lead sponsor
- Novartis Pharmaceuticals13 trials
Running trials
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations
Active, not recruiting
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Hidradenitis suppurativa1 recruiting
- Multiple sclerosis1 recruiting
Closed trials
Completed
Completed
Completed
Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026